Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementing and Sustaining a Transdiagnostic Sleep and Circadian Treatment to Improve Severe Mental Illness Outcomes in Community Mental Health Part 1: Implementation

NCT04154631 is registered in ClinicalTrials.gov with University of California, Berkeley as lead sponsor.

NCT NCT04154631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04154631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementing and Sustaining a Transdiagnostic Sleep and Circadian Treatment to Improve Severe Mental Illness Outcomes in Community Mental Health Part 1: Implementation
Lead sponsor
University of California, Berkeley
Phase
Not applicable
Overall status
Completed
Start date
January 8, 2020
Completion date
December 19, 2023
Enrollment
489 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

circadian dysregulation, sleep disorder